Bladder carcinoma usually arises from the urothelium and is strongly linked to smoking and chemical exposure. It often ...

Recognizing common bladder cancer symptoms, such as blood in urine, can help you identify this disease in its early stages, when it may be more treatable.

Squamous cell carcinoma (SCC) of the bladder is a distinct and rarer form, accounting for approximately 2% to 5% of all bladder cancers in the U.S. It develops in the flat, thin squamous cells that ...

Patients with initially low- or intermediate-risk primary tumors will often have a high-risk recurrence before progressing to more advanced disease, whereas primary high-risk tumors typically show ...

Johnson & Johnson (NYSE:JNJ) announced today that new data from the investigational Cohort 4 of the Phase 2b SunRISe-1 study show treatment with gemcitabine intravesical system resulted in high ...

Some types and grades of bladder cancer spread quickly. Doctors can treat this disease in several ways. However, treatments are most effective before bladder cancer spreads. The bladder is a hollow ...

Clinical study launched in June 2022 with patient recruitment in Alberta with plans to expand to further sites across North America. The aim of the study is to validate a novel and minimally invasive ...

The risk for alzheimer disease decreased with increased dosing of BCG. Bladder instillations of bacillus Calmette-Guérin (BCG) in patients with nonmuscle-invasive bladder cancer (NMIBC) are associated ...

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...

Cretostimogene demonstrated HG-EFS at 3- 6- and 9-months of 95.7%, 84.6% and 80.4%, respectively, in HR BCG UR Ta/T1 Disease in BOND-003 Cohort ...

Johnson & Johnson's Inlexzo shows promising survival rates in BCG-unresponsive NMIBC patients. Read more here.